272 related articles for article (PubMed ID: 29093108)
1. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
[TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
Kurabayashi K; Tanimoto K; Fueki S; Tomita H; Hirakawa H
Antimicrob Agents Chemother; 2015 Oct; 59(10):6352-60. PubMed ID: 26248376
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into fosfomycin resistance in Escherichia coli.
Ballestero-Téllez M; Docobo-Pérez F; Portillo-Calderón I; Rodríguez-Martínez JM; Racero L; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
J Antimicrob Chemother; 2017 May; 72(5):1303-1309. PubMed ID: 28093485
[TBL] [Abstract][Full Text] [Related]
4. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
5. Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK.
Cottell JL; Webber MA
J Med Microbiol; 2019 Feb; 68(2):161-168. PubMed ID: 30543320
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Reduced Susceptibility to Fosfomycin in
Ohkoshi Y; Sato T; Suzuki Y; Yamamoto S; Shiraishi T; Ogasawara N; Yokota SI
Biomed Res Int; 2017; 2017():5470241. PubMed ID: 28197413
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China.
Li Y; Zheng B; Li Y; Zhu S; Xue F; Liu J
PLoS One; 2015; 10(8):e0135269. PubMed ID: 26252888
[TBL] [Abstract][Full Text] [Related]
8. How is fosfomycin resistance developed in Escherichia coli?
Cattoir V; Guérin F
Future Microbiol; 2018 Dec; 13():1693-1696. PubMed ID: 30526061
[No Abstract] [Full Text] [Related]
9. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
Takahata S; Ida T; Hiraishi T; Sakakibara S; Maebashi K; Terada S; Muratani T; Matsumoto T; Nakahama C; Tomono K
Int J Antimicrob Agents; 2010 Apr; 35(4):333-7. PubMed ID: 20071153
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
[TBL] [Abstract][Full Text] [Related]
11. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.
Nakamura G; Wachino J; Sato N; Kimura K; Yamada K; Jin W; Shibayama K; Yagi T; Kawamura K; Arakawa Y
J Clin Microbiol; 2014 Sep; 52(9):3175-9. PubMed ID: 24951800
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.
Tseng SP; Wang SF; Kuo CY; Huang JW; Hung WC; Ke GM; Lu PL
PLoS One; 2015; 10(8):e0135864. PubMed ID: 26280832
[TBL] [Abstract][Full Text] [Related]
13. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
14. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
[TBL] [Abstract][Full Text] [Related]
15. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
[TBL] [Abstract][Full Text] [Related]
16. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel two-component regulatory system, HptRS, the regulator for the hexose phosphate transport system in Staphylococcus aureus.
Park JY; Kim JW; Moon BY; Lee J; Fortin YJ; Austin FW; Yang SJ; Seo KS
Infect Immun; 2015 Apr; 83(4):1620-8. PubMed ID: 25644013
[TBL] [Abstract][Full Text] [Related]
18. Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli.
Ma Y; Xu X; Guo Q; Wang P; Wang W; Wang M
Lett Appl Microbiol; 2015 Mar; 60(3):259-64. PubMed ID: 25441705
[TBL] [Abstract][Full Text] [Related]
19. Rapid Detection of Fosfomycin Resistance in Escherichia coli.
Nordmann P; Poirel L; Mueller L
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30381418
[TBL] [Abstract][Full Text] [Related]
20. Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains.
Galán JC; Tato M; Baquero MR; Turrientes C; Baquero F; Martinez JL
J Clin Microbiol; 2004 Sep; 42(9):4310-2. PubMed ID: 15365030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
